Expanded Access to Omaveloxolone for Melanoma for Patients Previously Enrolled in 408-C-1401

NCT03593499 · clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Biogen